SRI-81™ is the most clinically researched Shatavari on the market.

Ixoreal is the industry leader in research and clinical trials investigating the effect of Shatavari, with 10+ studies. It collaborates with major academic and research institutes. All of Ixoreal-partnered clinical studies follow the gold standards of substantiation: randomized, double-blind, placebo-controlled designs. The studies have been conducted on healthy population and are published in PubMed-indexed peer reviewed journals. Our research studies focus on the main applications of Shatavari as listed below.

Clinical Studies


Lactation Support

Title: Shatavari (Asparagus racemosus Willd) Root Extract for Postpartum Lactation: A Randomized, Double-Blind, Placebo-Controlled Study.

study-dose

Study Dose: 300 mg/day

duration

Study Duration: 72 hours

No-of-Participants

No. of Participants: 113

Conclusion: The study demonstrated that Shatavari root extract (300 mg/day) significantly enhanced lactation within 72 hours with a significant decrease in time to noticeable breast fullness. An increase in milk volume and improved maternal satisfaction, as indicated by well-being and happiness scores, was observed. The supplementation was well-tolerated, with no adverse events reported.

graph
graph
Ashutosh Ajgaonkar , Tanisha Debnath , Sunanda Bhatnagar , Khokan Debnath & Jayshree Langade (2025) Shatavari (Asparagus racemosus Willd) root extract for postpartum lactation: A randomised, double-blind, placebo-controlled study, Journal of Obstetrics and Gynaecology, 45:1, 2564168

Sexual Function in Women

Title: Shatavari (Asparagus racemosus) Root Extract Improves Sexual Wellness in Women: Findings from a Prospective, Randomized, Double-Blind, Three-arm, Parallel-Group, Placebo-Controlled Study.

study-dose

Study Dose: 300 mg/day

duration

Study Duration: 8 weeks

No-of-Participants

No. of Participants: 127

Conclusion: The study demonstrated that Shatavari root extract significantly improved sexual wellness, with a 34.2% increase in total Female Sexual Function Index scores and a significant increase in arousal, lubrication, satisfaction, and orgasm. It also reduced sexual distress by 28.7%, improved mood and sleep, and balanced key reproductive hormones, supporting its role in enhancing overall female sexual health.

graph
graph
Shatavari (Asparagus racemosus) Root Extract Improves Sexual Wellness in Women: Findings from a Prospective, Randomized, Double-Blind, Three-arm, Parallel-Group, Placebo-Controlled Study (Under Peer Review)

Managing PCOS in Women

Title: A Randomized, Double-Blind, Two-Arm, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Shatavari in Women with Polycystic Ovarian Disease Syndrome (PCOS).

study-dose

Study Dose: 300 mg/day

duration

Study Duration: 12 weeks

No-of-Participants

No. of Participants: 66

Conclusion: In this study, Shatavari root extract demonstrated significant improvements in hormonal and reproductive parameters. The Perceived Stress Scale (PSS) score decreased by 19.05%. Significant reductions were observed in ovarian volume (17.72%), follicle count (28.6%), and endometrial thickness (25.98%), suggesting potential hormonal balancing effects. Hormonal markers also showed mild to moderate reductions, including FSH, LH, estradiol, total testosterone, progesterone, and DHEA-S.

graph
graph
A Randomized, Double-Blind, Two-Arm, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Shatavari in Women with Polycystic Ovarian Disease Syndrome (PCOS) (Under Peer Review)

Perimenopausal Symptoms in Women

Title: Efficacy and Safety of Shatavari for Treatment of Perimenopausal Symptoms in Women: A Randomized, Double-blind, Two-arm, Parallel, Placebo-controlled Study.

study-dose

Study Dose: 300 mg/day

duration

Study Duration: 8 weeks

No-of-Participants

No. of Participants: 73

Conclusion: A study in perimenopausal women showed that Shatavari root extract significantly improved climacteric symptoms, with a 42.6% reduction in total Menopause Rating Scale scores and significant improvement across somato-vegetative, psychological, and urogenital domains. Stress scores reduced by 29.6%, hot flashes by 25.9%, and mood disturbances significantly improved. There was also a 32.8% increase in serum estradiol, supporting Shatavari’s role in easing the transition through perimenopause.

graph
graph
Mahajan S,et al., (2025). Efficacy and Safety of Shatavari (Asparagus racemosus) Root Extract for Perimenopause: A Randomized,Double-Blind,Placebo-Controlled Study. International Journal of Women's Health

Menopausal Symptoms in Women

Title: Efficacy and Safety of Shatavari Root Extract (Asparagus racemosus) for Menopausal Symptoms: A Randomized, Double-blind, Three-arm, Placebo-controlled Study.

study-dose

Study Dose: 300 mg/day

duration

Study Duration: 8 weeks

No-of-Participants

No. of Participants: 125

Conclusion: A study in menopausal women showed that Shatavari root extract significantly improved menopausal symptoms. The total Menopause Rating Scale score significantly decreased by 44.7%, with reductions in somato-vegetative (36.17%), psychological (37.14%), and urogenital (29.81%) domains. Also, a 16.95% reduction in perceived stress and a 57.95% decrease in hot flashes were observed. Quality of life and hormone balance also improved, confirming Shatavari’s efficacy in managing menopause naturally.

graph
graph
Ademola J, and Ajgaonkar, A. et al., (2025). Efficacy and Safety of Shatavari Root Extract (Asparagus racemosus) for Menopausal Symptoms: Randomized, Double-blind, Three-arm, Placebo-controlled Study. Frontiers in Reproductive Health.